OPEN ACCESS pISSN 2234-3806
eISSN 2234-3814

Table. 1.

Table. 1.

Model input

Parameters Baseline values
Cost ($)
Germline testing 76.6
Somatic testing 714.0
Olaparib treatment (30 days) 243.3
Niraparib treatment (30 days) 174.8
Monitoring in treatment (24 months) 109.4
Monitoring in observation (24 months) 42.3
PF-LYG (y)
Olaparib maintenance monotherapy 3.52
Niraparib maintenance monotherapy 0.93
Probability (%)
Prevalence of germline BRCA variant in OC 13.1
Prevalence of somatic BRCA variant in OC 5.4
Proportion of olaparib use (niraparib use) 50 (50)

Abbreviations: PF-LYG, progression-free life-year gain; OC, ovarian cancer.

© Ann Lab Med